| Up
2006P-0298:
To permit an ANDA Suitability for Eloxatin (Oxaliplatin for injection)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 07/25/2006
|
| 07/25/2006
|
| Private Industry
|
| AAC Consulting Group
|
|
|
|
|
|
|
| pdf
Ex
1, Ex
2
|
|
|
|
|
| Signature:
|
| Anthony Celeste
|
|
|
|
|
| ACK1
|
| 07/25/2006
|
| 07/25/2006
|
| Federal Government
|
| FDA/ DDM to AAC Consulting
Group
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Jennie C. Butler
|
|
Top | Up
Page last updated
August 14, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
